Journal of Clinical Virology

Papers
(The H4-Index of Journal of Clinical Virology is 64. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19742
Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past648
Low performance of rapid antigen detection test as frontline testing for COVID-19 diagnosis455
Prevalence and severity of corona virus disease 2019 (COVID-19): A systematic review and meta-analysis440
Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, China410
Evaluation of rapid antigen test for detection of SARS-CoV-2 virus379
Comparison of seven commercial RT-PCR diagnostic kits for COVID-19362
SARS-CoV-2-specific antibody detection in healthcare workers in Germany with direct contact to COVID-19 patients285
Diabetic patients with COVID-19 infection are at higher risk of ICU admission and poor short-term outcome283
Epidemiology and clinical features of COVID-19: A review of current literature269
COVID-19 and telemedicine: Immediate action required for maintaining healthcare providers well-being251
Epidemiological characteristics of coronavirus disease 2019 (COVID-19) patients in IRAN: A single center study239
Evaluation of two automated and three rapid lateral flow immunoassays for the detection of anti-SARS-CoV-2 antibodies224
Evaluation of the EUROIMMUN Anti-SARS-CoV-2 ELISA Assay for detection of IgA and IgG antibodies212
Assessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: Two automated immunoassays (Euroimmun and Abbott) and one rapid lateral flow immu196
The clinical course and its correlated immune status in COVID-19 pneumonia185
Panbio antigen rapid test is reliable to diagnose SARS-CoV-2 infection in the first 7 days after the onset of symptoms185
Performance of six SARS-CoV-2 immunoassays in comparison with microneutralisation169
Urgent need of rapid tests for SARS CoV-2 antigen detection: Evaluation of the SD-Biosensor antigen test for SARS-CoV-2164
Brief clinical evaluation of six high-throughput SARS-CoV-2 IgG antibody assays161
Comparison of Cepheid Xpert Xpress and Abbott ID Now to Roche cobas for the Rapid Detection of SARS-CoV-2154
Quantification of SARS-CoV-2 antibodies with eight commercially available immunoassays136
Challenges in use of saliva for detection of SARS CoV-2 RNA in symptomatic outpatients135
Gastrointestinal, hepatobiliary, and pancreatic manifestations of COVID-19131
Dynamic profile of RT-PCR findings from 301 COVID-19 patients in Wuhan, China: A descriptive study126
Epidemiological characteristics and clinical features of 32 critical and 67 noncritical cases of COVID-19 in Chengdu126
Clinical characteristics and risk assessment of newborns born to mothers with COVID-19125
Multi-center evaluation of cepheid xpert® xpress SARS-CoV-2 point-of-care test during the SARS-CoV-2 pandemic123
Profiling COVID-19 pneumonia progressing into the cytokine storm syndrome: Results from a single Italian Centre study on tocilizumab versus standard of care121
Comparison of four new commercial serologic assays for determination of SARS-CoV-2 IgG115
Supportive Treatment with Tocilizumab for COVID-19: A Systematic Review114
Prevalence, clinical characteristics, and outcomes of pediatric COVID-19: A systematic review and meta-analysis109
Longitudinal follow-up of IgG anti-nucleocapsid antibodies in SARS-CoV-2 infected patients up to eight months after infection107
Comparing the analytical performance of three SARS-CoV-2 molecular diagnostic assays104
Predictive factors for disease progression in hospitalized patients with coronavirus disease 2019 in Wuhan, China104
Real-time PCR-based SARS-CoV-2 detection in Canadian laboratories96
Combination of four clinical indicators predicts the severe/critical symptom of patients infected COVID-1995
Evaluation of a novel multiplexed assay for determining IgG levels and functional activity to SARS-CoV-292
Evaluation of a SARS-CoV-2 rapid antigen test: Potential to help reduce community spread?91
Clinical characteristics of 225 patients with COVID-19 in a tertiary Hospital near Wuhan, China90
Self-collection: An appropriate alternative during the SARS-CoV-2 pandemic89
Evaluation of rapid diagnosis of novel coronavirus disease (COVID-19) using loop-mediated isothermal amplification88
Characterisation of COVID-19 Pandemic in Paediatric Age Group: A Systematic Review and Meta-Analysis88
Performance of the rapid high-throughput automated electrochemiluminescence immunoassay targeting total antibodies to the SARS-CoV-2 spike protein receptor binding domain in comparison to the neutrali87
Epidemiologic and clinical characteristics of 10 children with coronavirus disease 2019 in Changsha, China86
Evidence and possible mechanisms of rare maternal-fetal transmission of SARS-CoV-285
Clinical evaluation of an immunochromatographic IgM/IgG antibody assay and chest computed tomography for the diagnosis of COVID-1985
Analytical sensitivity and clinical sensitivity of the three rapid antigen detection kits for detection of SARS-CoV-2 virus84
Significant impact of nationwide SARS-CoV-2 lockdown measures on the circulation of other respiratory virus infections in Austria83
High-Throughput Transcription-mediated amplification on the Hologic Panther is a highly sensitive method of detection for SARS-CoV-282
SARS-CoV-2 detection by direct rRT-PCR without RNA extraction81
Multi-Stage Group Testing Improves Efficiency of Large-Scale COVID-19 Screening79
SARS-CoV-2 exhibits intra-host genomic plasticity and low-frequency polymorphic quasispecies78
Evaluation of the COVID19 ID NOW EUA assay78
Performance evaluation of Abbott ARCHITECT SARS-CoV-2 IgG immunoassay in comparison with indirect immunofluorescence and virus microneutralization test77
Comparison of the diagnostic sensitivity of SARS-CoV-2 nucleoprotein and glycoprotein-based antibody tests71
Longitudinal characterization of the IgM and IgG humoral response in symptomatic COVID-19 patients using the Abbott Architect70
A combined oropharyngeal/nares swab is a suitable alternative to nasopharyngeal swabs for the detection of SARS-CoV-270
Identification of multiple large deletions in ORF7a resulting in in-frame gene fusions in clinical SARS-CoV-2 isolates69
Extraction-free SARS-CoV-2 detection by rapid RT-qPCR universal for all primary respiratory materials68
Comparison of the analytical sensitivity of seven commonly used commercial SARS-CoV-2 automated molecular assays68
Comparison of commercial realtime reverse transcription PCR assays for the detection of SARS-CoV-268
Clinical features of pediatric patients with coronavirus disease (COVID-19)67
Rapid and sensitive detection of SARS-CoV-2 RNA using the Simplexa™ COVID-19 direct assay66
0.052489995956421